Scott T. Garrett, Director at HCW Biologics Inc. (HCWB), bought 26,846 shares at $7.45 ($200K) on 2025-05-16, disclosed to the SEC on 2025-05-20.
Open-market purchase of $200k HCWB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.45 | 13,423 | $100K | 50.0% |
| 2 | $7.45 | 13,423 | $100K | 50.0% |
| Total | $7.45 avg | 26,846 | $200K | 100% |
| Filing → |
| HCWB | BUY | 2025-05-09 | $140K | — | Filing → |
| HOLX | SELL | 2024-03-15 | $2.5M | — | Filing → |
| HOLX | SELL | 2023-12-13 | $1.4M | — | Filing → |